Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
CJ Grubbs
Observed names:
C. J. Grubbs,
CJ. Grubbs
Institutions:
University of Alabama at Birmingham,
National Cancer Institute
Observed institutions:
National Institutes of Health,
University of Minnesota,
Medical College of Wisconsin,
Washington University in St. Louis,
Hormel (United States),
University of Alabama at Birmingham,
National Cancer Institute
show all 7
OpenAlex ID:
A5113591785
Effects of Folate Deficiency and Supplementation on Methylnitrosourea-Induced Rat Mammary Tumors
1992
·
J. E. Baggott
, W. H. Vaughn
, et al.
·
JNCI Journal of the National Cancer Institute
·
96
P3-10-01: Alternative Dosing Regimens with the EGFr Inhibitors (Gefitinib and Lapatinib) in Mammary Cancer Models: Prevention and Therapeutic Efficacy.
2011
·
RA Lubet
, AM Bode
, et al.
·
Cancer Research
·
2
Abstract P5-14-02: Effects of bazedoxifene and/or letrozole in the prevention of chemically-induced mammary cancers
2018
·
BK Dunn
, CJ Grubbs
·
Cancer Research
Abstract P3-11-04: Metabolic profiles in female Sprague-Dawley rats receiving either a standard (4% fat) or Western (20% fat) diet and changes in rats bearing mammary cancers
2016
·
MD Thompson
, CJ Grubbs
, et al.
·
Cancer Research
Abstract P1-08-01: Effects Of An Allosteric AKT Inhibitor (MK2206) Administered With Or Without The Aromatase Inhibitor Vorozole In An ER+ Rat Mammary Cancer Model: Preventive And Therapeutic Effects
2012
·
RA Lubet
, MJ Ellis
, et al.
·
Cancer Research
P3-10-02: Gene Expression Changes in Methylnitrosourea (MNU)-Induced ER+ Mammary Cancers Following Short-Term Treatment of Rats with the Aromatase Inhibitor Vorozole.
2011
·
RA Lubet
, CJ Grubbs
, et al.
·
Cancer Research
P3-10-03: Bardoxolone (5MeCDDO) Inhibits Cancer Initiation but Promotes Progression in Rodent Models of Breast Cancer. What Does It Mean for the Antioxidant Response Element (ARE) as a Primary Prevention Target?
2011
·
RA Lubet
, R Townsend
, et al.
·
Cancer Research
P3-11-07: Mammary Gland Biopsy To Examine Surrogate Endpoint Biomarkers of Preventive Agent Efficacy.
2011
·
B Heckman-Stoddard
, RA Lubet
, et al.
·
Cancer Research
Abstract P1-08-04: Doses of Selective Estrogen Receptor Modulations (SERMS) Required for Prevention and Therapy of Chemically-Induced Mammary Cancers
2010
·
BM Heckman-Stoddard
, CJ Grubbs
, et al.
·
Cancer Research
Abstract PD03-07: Evaluation of the Anti-Diabetic Drug Metformin in the Methylnitrosourea (MNU)-Induced Model of ER+ Mammary Cancer and the MMTV-Neu/p53KO Model of ER-Mammary Cancer
2010
·
CJ Grubbs
, AM Bode
, et al.
·
Cancer Research
Abstract P1-08-03: Alternative Dosing Regimens with Tarceva in a Mammary Cancer Model: Effects on Efficacy and Potential Effects on Toxicity
2010
·
RA Lubet
, K Iwata
, et al.
·
Cancer Research
Identification of urinary biomarkers to distinguish tumor bearing and control rats in the methylnitrosourea (MNU) – induced model of mammary carcinogenesis: use of label-free, comparative, ultra-high resolution nano-LC mass spectrometry.
2009
·
RR Townsend
, H Rohrs
, et al.
·
Cancer Research
Effects of methyl derivatives of the rexinoid UAB30 on methylnitrosourea (MNU) induced mammary cancers and on various indicators of toxicity.
2009
·
DD Muccio
, RA Lubet
, et al.
·
Cancer Research
Preventive effects of the EGFr inhibitor erlotinib in ER+ methylnitrosourea (MNU) induced and in ER- MMTV/Neu/P53KO mammary cancer models.
2009
·
CJ Grubbs
, KK Iwata
, et al.
·
Cancer Research
Efficacy of Ethylvanillin in the Prevention of Mammary Tumors Induced by Methylnitrosourea (MNU) in the Rats
1994
·
C. J. Grubbs
, T. L. Casebolt
, et al.
·
Advances in experimental medicine and biology
Show more works
View as search
Works count:
15
Citation count:
98
H-index:
2
I10-index:
1
Year
Topic
Type